JP2009533433A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009533433A5 JP2009533433A5 JP2009505389A JP2009505389A JP2009533433A5 JP 2009533433 A5 JP2009533433 A5 JP 2009533433A5 JP 2009505389 A JP2009505389 A JP 2009505389A JP 2009505389 A JP2009505389 A JP 2009505389A JP 2009533433 A5 JP2009533433 A5 JP 2009533433A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- humans
- food
- pyruvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 27
- 241000282412 Homo Species 0.000 claims 8
- 235000015872 dietary supplement Nutrition 0.000 claims 7
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical group CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 claims 4
- 230000002708 enhancing effect Effects 0.000 claims 4
- 229940117360 ethyl pyruvate Drugs 0.000 claims 4
- 235000013305 food Nutrition 0.000 claims 3
- 150000001720 carbohydrates Chemical class 0.000 claims 2
- 235000014633 carbohydrates Nutrition 0.000 claims 2
- 235000013373 food additive Nutrition 0.000 claims 2
- 239000002778 food additive Substances 0.000 claims 2
- 230000004060 metabolic process Effects 0.000 claims 2
- PUKLDDOGISCFCP-JSQCKWNTSA-N 21-Deoxycortisone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2=O PUKLDDOGISCFCP-JSQCKWNTSA-N 0.000 claims 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims 1
- 241001116389 Aloe Species 0.000 claims 1
- 206010003805 Autism Diseases 0.000 claims 1
- 208000020706 Autistic disease Diseases 0.000 claims 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims 1
- FCYKAQOGGFGCMD-UHFFFAOYSA-N Fulvic acid Natural products O1C2=CC(O)=C(O)C(C(O)=O)=C2C(=O)C2=C1CC(C)(O)OC2 FCYKAQOGGFGCMD-UHFFFAOYSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 235000011399 aloe vera Nutrition 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims 1
- 230000019771 cognition Effects 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 206010013781 dry mouth Diseases 0.000 claims 1
- 239000003792 electrolyte Substances 0.000 claims 1
- 239000000284 extract Substances 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 229940095100 fulvic acid Drugs 0.000 claims 1
- 239000002509 fulvic acid Substances 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 230000035876 healing Effects 0.000 claims 1
- 210000002216 heart Anatomy 0.000 claims 1
- 235000008216 herbs Nutrition 0.000 claims 1
- 238000006703 hydration reaction Methods 0.000 claims 1
- 201000006747 infectious mononucleosis Diseases 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 230000036651 mood Effects 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims 1
- 210000000944 nerve tissue Anatomy 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000000021 stimulant Substances 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000000341 volatile oil Substances 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74473906P | 2006-04-12 | 2006-04-12 | |
| PCT/US2007/008334 WO2007120544A2 (en) | 2006-04-12 | 2007-04-04 | Compositions comprising pyruvate alkyl esters and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009533433A JP2009533433A (ja) | 2009-09-17 |
| JP2009533433A5 true JP2009533433A5 (cg-RX-API-DMAC7.html) | 2010-05-13 |
Family
ID=38610076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009505389A Pending JP2009533433A (ja) | 2006-04-12 | 2007-04-04 | ピルビン酸アルキルエステルを含む組成物とその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20100047221A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2010218B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009533433A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101472613A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007238938B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2683664C (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ572649A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007120544A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120046361A1 (en) * | 2010-08-20 | 2012-02-23 | American Symbolic, Llc | Ethyl pyruvate compositions and methods |
| CN113876014B (zh) * | 2021-09-06 | 2022-10-18 | 湖北中烟工业有限责任公司 | 一种含有烷基化甘油的雾化剂及其制备方法和应用 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4158057A (en) * | 1975-03-28 | 1979-06-12 | Stanko Ronald T | Prevention of the accumulation of fatty deposits in the liver |
| GB1603724A (en) * | 1977-05-25 | 1981-11-25 | Montedison Spa | Components and catalysts for the polymerisation of alpha-olefins |
| US4174742A (en) * | 1978-02-08 | 1979-11-20 | Murphey James D | Method and apparatus for making and dispensing snow cones |
| US4491597A (en) | 1981-01-26 | 1985-01-01 | Scm Corporation | Candy bar |
| US4351835A (en) | 1981-04-01 | 1982-09-28 | Montefiore Hospital | Method for preventing body fat deposition in mammals |
| US4415576A (en) * | 1981-04-01 | 1983-11-15 | Montefiore Hospital | Method for preventing body fat deposition in mammals |
| US4548937A (en) | 1981-04-01 | 1985-10-22 | Montefiore Hospital | Method for preventing body fat deposition in mammals |
| US4812479A (en) * | 1981-04-01 | 1989-03-14 | The Montefiore Hospital Society Of Western Pennsylvania, Inc. | Method for preventing body fat deposition in mammals |
| JPS59104326A (ja) * | 1982-12-04 | 1984-06-16 | Toyo Jozo Co Ltd | マクロライド抗生物質の安定な経口用製剤および安定化法 |
| US5389677B1 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Method of treating wrinkles using glycalic acid |
| US4981687A (en) * | 1988-07-29 | 1991-01-01 | University Of Florida | Compositions and methods for achieving improved physiological response to exercise |
| US5236712A (en) * | 1988-07-29 | 1993-08-17 | University Of Florida | Compositions and methods for achieving improved physiological response to exercise |
| US4874790A (en) * | 1988-08-15 | 1989-10-17 | Montefiore Hospital Association Of Western Pennsylvania | Method for improving the glucose metabolism of an animal having diabetic tendencies |
| US5134162A (en) * | 1990-12-24 | 1992-07-28 | The Montefiore Hospital Association Of Western Pennsylvania | Method for lowering high blood cholesterol levels in hyperlipidemic animals and confections as the ingestion medium |
| US5294641A (en) | 1991-11-27 | 1994-03-15 | Montefiore - University Hospital | Method for treating a medical patient for cardiac trauma |
| US5256597A (en) * | 1992-09-04 | 1993-10-26 | International Business Machines Corporation | Self-aligned conducting etch stop for interconnect patterning |
| SE9303691D0 (sv) * | 1993-11-09 | 1993-11-09 | Gramineer Ab | New beverage |
| US5612374A (en) * | 1994-02-14 | 1997-03-18 | Ronald T. Stanko | Inhibiting growth of mammary adenocarcinoma |
| US5480909A (en) * | 1994-08-08 | 1996-01-02 | University Of Pittsburgh Medical Center | Method for inhibiting generation of free-radicals |
| US5621996A (en) | 1995-06-07 | 1997-04-22 | Pride Cast Metals, Inc. | Combination security and display device for firearms |
| US5801198A (en) | 1995-07-13 | 1998-09-01 | University Of Pittsburgh Medical Center | Retarding neutrophil infiltration ad morphologic reduction in ischemic bowel tissues |
| US5876916A (en) * | 1996-03-18 | 1999-03-02 | Case Western Reserve University | Pyruvate compounds and methods for use thereof |
| US5716926A (en) * | 1996-07-26 | 1998-02-10 | Paxton K. Beale | Composition of pyruvate and protein and method for increasing protein concentration in a mammal |
| US6417231B1 (en) * | 1996-12-23 | 2002-07-09 | Frank L. Greenway | Method and composition for delivering therapeutically effective amounts of pyruvate to a mammal |
| US5973005A (en) * | 1998-02-26 | 1999-10-26 | Bio-Bontanica, Inc. | Aqueous creatine solution and process of producing a stable, bioavailable aqueous creatine solution |
| US5976550A (en) * | 1998-11-20 | 1999-11-02 | Engel; Peter H. | Dietary food supplement |
| US6846842B2 (en) * | 1999-10-07 | 2005-01-25 | Beth Israel Deconess Medical Center, Inc. | Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| DE60027319T2 (de) * | 1999-10-07 | 2007-04-05 | Xanthus Life Sciences, Inc., Montreal | Pyruvatesterzusammenstellung und verwendungsmethode zur wiederbelebung nach ischemie- und reperfusionsvorfällen |
| GB0011676D0 (en) * | 2000-05-15 | 2000-07-05 | Unilever Plc | Ambient stable beverage |
| GB0011674D0 (en) * | 2000-05-15 | 2000-07-05 | Unilever Plc | Ambient stable beverage |
| GB0011675D0 (en) * | 2000-05-15 | 2000-07-05 | Unilever Plc | Ambient stable beverage |
| WO2002074301A1 (en) * | 2001-03-15 | 2002-09-26 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| CA2481749A1 (en) * | 2002-04-17 | 2003-10-30 | Critical Therapeutics, Inc. | Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt |
| US20050032891A1 (en) * | 2003-06-13 | 2005-02-10 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Method for treating alcoholic hepatitis |
| WO2005044299A1 (en) * | 2003-10-27 | 2005-05-19 | University Of Pennsylvania | Cytoprotective effects of ethyl pyruvate |
| WO2005094236A2 (en) * | 2003-11-07 | 2005-10-13 | Henry M. Jackson Foundation | Activation of hypoxia-inducible gene expression |
| US20060025475A1 (en) * | 2004-07-29 | 2006-02-02 | Stanley Antosh | Use of methyl pyruvate for the purpose of increasing muscle energy production. |
| US20100204161A1 (en) | 2005-04-15 | 2010-08-12 | Biomac Privatinstitut Fur Medizinishe Und Zahmediz Forschung, Entwicklung Und Diagnostik Gmbh | Substances and Pharmaceutical Compositions for the Inhibition of Glyoxalases and Their Use Against Bacteria |
| US20080153897A1 (en) * | 2006-09-11 | 2008-06-26 | New Cell Formulations Ltd. | Creatine pyroglutamic acid salts and methods for their production and use in individuals |
-
2007
- 2007-04-04 US US12/296,527 patent/US20100047221A1/en not_active Abandoned
- 2007-04-04 NZ NZ572649A patent/NZ572649A/en not_active IP Right Cessation
- 2007-04-04 AU AU2007238938A patent/AU2007238938B2/en not_active Ceased
- 2007-04-04 EP EP07754798.2A patent/EP2010218B1/en not_active Not-in-force
- 2007-04-04 JP JP2009505389A patent/JP2009533433A/ja active Pending
- 2007-04-04 CN CNA2007800216659A patent/CN101472613A/zh active Pending
- 2007-04-04 WO PCT/US2007/008334 patent/WO2007120544A2/en not_active Ceased
- 2007-04-04 CA CA2683664A patent/CA2683664C/en not_active Expired - Fee Related
-
2015
- 2015-02-18 US US14/624,854 patent/US20150157589A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101248873A (zh) | 具有视力保护功能的饮用食品 | |
| WO2007103160A3 (en) | Stearidonic acid for improving cardiovascular health | |
| CN102960808A (zh) | 解酒抗疲劳饮料 | |
| US20180104269A1 (en) | Composition for suppressing muscular fatty change | |
| CN101766715B (zh) | 解酒醒酒组合物 | |
| CN105661234A (zh) | 一种迅速恢复体能的饮料及其制备方法 | |
| US20100179089A1 (en) | Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly | |
| CN101766672B (zh) | 解酒醒酒组合物 | |
| JP2009533433A5 (cg-RX-API-DMAC7.html) | ||
| CN110801018A (zh) | 辅酶q10维生素c运动含片 | |
| CN101306009A (zh) | 一种用于护肝养肝的功能食品 | |
| CN101336723A (zh) | 一种用于缓解体力疲劳的保健食品 | |
| CN106963749A (zh) | α‑酮戊二酸（盐）在抗疲劳和提高肌肉运动力量方面的应用 | |
| Joshi et al. | Sportsmen’s energy package Cordyceps sinensis: Medicinal importance and responsible phytochemical constituents | |
| KR20120119686A (ko) | Ｌ-아르기닌, 비타민ｃ, 비타민 ｂ군, 비타민ａ, 비타민ｅ 및 요오드화칼륨을 주성분으로 함유하는 기능성 음료조성물 | |
| CN102488049A (zh) | 红景天咖啡 | |
| CN101766716B (zh) | 解酒醒酒组合物 | |
| CN102166029A (zh) | 一种仙草多菌养生精功能饮料 | |
| CN101589831A (zh) | 一种多营养蛋白饮料 | |
| CN102488067B (zh) | 一种含灵芝的养生枣及其制备方法 | |
| JP2009533433A (ja) | ピルビン酸アルキルエステルを含む組成物とその使用 | |
| RU2429868C2 (ru) | Способ повышения экономичности деятельности сердечно-сосудистой системы при мышечной нагрузке | |
| Opie | Cardioprotection from metabolism to molecules to certainties: forum-analysis | |
| CN105265981A (zh) | 一种辅助减肥和降三高的植物蛋白功能饮料冲剂 | |
| CN104642848A (zh) | 一种葵花杜鹃养颜蜂蜜 |